Cargando…
Acute Corticotropin-Releasing Factor Receptor Type 2 Agonism Results in Sustained Symptom Improvement in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
BACKGROUND: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex multi-symptom disease with widespread evidence of disrupted systems. The authors hypothesize that it is caused by the upregulation of the corticotropin-releasing factor receptor type 2 (CRFR2) in the raphé nuclei an...
Autores principales: | Pereira, Gerard, Gillies, Hunter, Chanda, Sanjay, Corbett, Michael, Vernon, Suzanne D., Milani, Tina, Bateman, Lucinda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441022/ https://www.ncbi.nlm.nih.gov/pubmed/34539356 http://dx.doi.org/10.3389/fnsys.2021.698240 |
Ejemplares similares
-
Will COVID-19 Lead to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?
por: Komaroff, Anthony L., et al.
Publicado: (2021) -
Metabolomic Evidence for Peroxisomal Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
por: Che, Xiaoyu, et al.
Publicado: (2022) -
Orthostatic Challenge Causes Distinctive Symptomatic, Hemodynamic and Cognitive Responses in Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
por: Vernon, Suzanne D., et al.
Publicado: (2022) -
Evidence for Peroxisomal Dysfunction and Dysregulation of the CDP-Choline Pathway in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
por: Che, Xiaoyu, et al.
Publicado: (2022) -
Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
por: de Vega, Wilfred C., et al.
Publicado: (2017)